|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, October 17, 2019 ) Market Overview:
Cell sorting is a technique to separate cells on the basis of their intracellular and extracellular properties that is used in various research and medicinal applications. Cell sorting instruments are equipped with advanced features and functionalities to carry out various clinical studies.
Market Dynamics:
The Cell Sorting market is growing due to rising prevalence of cancer. For instance, according to a recent study (2018) by American Cancer Society epidemiologists, there were about 42% of newly cancers diagnosed in the US (about 729,000 cases in 2018). The incidence of all cancer types worldwide is anticipated to increase at a CAGR of 2.5% during 2015-2030.
Also, growing adoption of cell sorter techniques in clinical and research application, increasing funding and investments for the development of innovative cell sorting techniques are some of the other major factors driving the growth of the cell sorting market globally.
However, high cost of instrument and lack of awareness towards cell sorting technology in developing countries are some of the factors hindering the growth of the cell sorting market.
Market Segmentation:
On the basis of technology, the global market is segmented into fluorescence activated cell sorting (FACS), magnetic activated cell sorting (MACS), micro-Electromechanical Systems (MEMS) – Microfluidics, density gradient centrifugation, immunodensity cell separation, sedimentation, and others.
By product and services, the global market is segmented into cell sorters, reagents & consumables, and services. Among these, the cell sorters segment accounted for the largest market share in 2018, due to the increasing technological development of cell sorters, growing research activities globally.
Geographical Analysis:
By geography, the Market is segmented into North America, Asia-Pacific (APAC), Europe, South America, and the Middle East and Africa (MEA).
North America holds the dominant market share for cell sorting in 2018, and it is expected to maintain the growth over the forecast period, owing to the increasing number of pharmaceutical and biotechnology companies, rising prevalence of chronic and infectious diseases, and high investments and funding in cell-based research. According to the National Health council, chronic diseases affect approximately 133 million Americans, i.e. more than 40% of the total population of the U.S. By 2020, that number is projected to grow to an estimated 157 million, with 81 million having multiple conditions.
Competitive Analysis:
The Cell Sorting market is dominated by few major players including Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Merck KGaA, Danaher Corporation, Bio-Rad Laboratories, Agilent Technologies, Inc., Olympus Corporation, STEMCELL Technologies Inc., Miltenyi Biotec, and Sysmex Partec GmbH.
View full report: https://www.datamintelligence.com/research-report/cell-sorting-market
Download free sample: https://www.datamintelligence.com/download-sample/cell-sorting-market
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: pr@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
DataM Intelligence
Sai Kiran
+1 877 441 4866
pr@datamintelligence.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
